panagis galiatsatos md johns hopkins bayview medical center february 2 nd 2013 n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Panagis Galiatsatos , MD Johns Hopkins Bayview Medical Center February 2 nd 2013 PowerPoint Presentation
Download Presentation
Panagis Galiatsatos , MD Johns Hopkins Bayview Medical Center February 2 nd 2013

Loading in 2 Seconds...

  share
play fullscreen
1 / 21
dorjan

Panagis Galiatsatos , MD Johns Hopkins Bayview Medical Center February 2 nd 2013 - PowerPoint PPT Presentation

110 Views
Download Presentation
Panagis Galiatsatos , MD Johns Hopkins Bayview Medical Center February 2 nd 2013
An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. A Noninvasive, Hand-Held Device for Assessing Left Ventricular End-Diastolic Pressure Based on Finger Photoplethysmography and the Valsalva Maneuver PanagisGaliatsatos, MD Johns Hopkins Bayview Medical Center February 2nd 2013

  2. No Disclosures

  3. Outline • Background information • Objective of the study • Methods • Results • Conclusions • Future Direction

  4. Background Information • Knowledge of left ventricular filling pressure useful in certain clinical settings. • Non-invasive tools: • Physical Exam • Chest X-ray • Daily weights • Bloodwork (pro-BNP)

  5. Background Information Valsalva Maneuver - Created by Antonio Maria Valsalva - Effects on the cardiovascular system

  6. Background Information Valsalva Maneuver Phase 1: Initial blood pressure increase Phase 2: Maintaining the strain – decrease in pressure Phase 3: Release of the strain – short decrease of arterial pressure Phase 4: Distinct overshoot of pressure “Sinusoidal Response”

  7. Background Information Valsalva Maneuver Bedside technique with sphygmomanometry Issue 1. No standardization of technique 2. Does not yield continuous measure

  8. Background Information “Finger photoplethysmography during the Valsalva maneuver reflects left ventricular filling pressure” Silber HA et al. Am J Physiol Heart Circ Physiol 2012 Photoplethysmograph (PPG) Pulse Amplitude Ratio (PAR)

  9. Objective Validate a new hand-held, battery-powered device that inputs finger PPG and expiratory pressure signals during the Valsalva maneuver, guides subject performance and calculates PAR automatically.

  10. A Mouthpiece / pressure transducer Photoplethysmography (PPG) probe User-friendly display C B A C B

  11. Methods Patients who were scheduled to undergo a cardiac catheterization including the measurement of LVEDP. Expiratory pressure during Valsalva was measured by having the subject place a tube in their mouth that was connected to a pressure transducer input into the device.

  12. Methods The subject was coached to keep the expiratory effort at about 20 mmHg during a 10-second Valsalva maneuver. The output measure of the device is the ratio of the amplitude of the PPG waveform near the end of Valsalva to the amplitude at baseline

  13. Methods

  14. Results

  15. PAR > 0.72 was 78% sensitive and 100% specific in identifying LVEDP > 15 mmHg.

  16. Conclusions • This study represents initial testing of a hand-held, battery-powered device using finger PPG during the Valsalva maneuver for assessing left ventricular filling pressure noninvasively. • The output measure of the device, Pulse Amplitude Ratio (PAR), correlated well with LVEDP obtained invasively by cardiac catheterization.

  17. Conclusions • PAR > 0.72 was 78% sensitive and 100% specific in identifying LVEDP > 15 mmHg, a clinically meaningful cutoff value in heart failure. • Further testing is warranted to explore the clinical utility of this device in heart failure management and other settings.

  18. Future Directions • Use of the device to assess adequate fluid removal from in-patient diuresisin heart failure patients. • PAR in the use of fluid removal in hemodialysis.

  19. Acknowledgements • Harry Silber, MD, PhD • Principal Investigator • Jennifer Monti, MD, MPH • Interventional Cardiologists • David Bush, MD • Jeffrey C. Trost, MD • Peter Johnston, MD • Colleen Christmas, MD

  20. Questions